Hepatitis B

 

The hepatitis B virus is spread through blood, semen, and vaginal fluid. You can get hepatitis B if you have sex with an infected person, or if you share needles or works to inject drugs with someone who is infected.

As with hepatitis A, hepatitis B can make you feel sick for a short time. After that, most people with hepatitis B get rid of the virus. A small number (2% to 6%) of people who get hepatitis B infection fail to get rid of it, and go on to have chronic infection. This often leads to liver damage over time.

Once you have come into contact with hepatitis B, and the virus is no longer active in your body, you cannot become infected with it again.

There is a vaccine to prevent hepatitis B. People with a chronic liver disease should receive the vaccine to be protected from hepatitis B, unless they are already immune (determined by blood tests).

It is important that people with chronic liver disease who are not immune to hepatitis B receive the vaccine to protect themselves from it, since they can get quite sick if they contract the infection.

For much more information, please visit ourĀ Hepatitis B Center.

Latest Hepatitis News
Impressive Vertex hepatitis C drug data unveiled

November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.

Calif. court rejects limits on medical marijuana

January 22, 2010 — LOS ANGELES (Reuters) - The California Supreme Court on Thursday rejected limits on medical marijuana imposed by state lawmakers, finding that people with prescriptions for pot can have and grow all they need for personal use.

Study links thyroid disease to non-stick chemicals

January 21, 2010 — LONDON (Reuters) - Scientists have linked a chemical used in consumer goods like non-stick pans and water-resistant fabrics with thyroid disease, raising questions about the potential health risks of exposure to the substance.

US team finds potential path for hepatitis C drugs

January 21, 2010 — WASHINGTON (Reuters) - U.S. scientists have identified a new class of drugs that appear to block the hepatitis C virus from replicating in laboratory experiments, researchers said on Wednesday.

Select news items provided by Reuters Health